Editas Medicine, Inc. (EDIT) Net margin 2016–2025
Editas Medicine, Inc. (EDIT) net profit margin by fiscal year — reported net income divided by reported revenue.
-395.0%FY2025 · since FY2016: -1605.5% → -395.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -395.0% | +338.7 pp |
| FY2024 | -733.7% | -537.6 pp |
| FY2023 | -196.1% | +922.1 pp |
| FY2022 | -1118.3% | -364.7 pp |
| FY2021 | -753.6% | -625.8 pp |
| FY2020 | -127.8% | +523.6 pp |
| FY2019 | -651.4% | -307.2 pp |
| FY2018 | -344.3% | +532.2 pp |
| FY2017 | -876.5% | +729.0 pp |
| FY2016 | -1605.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice